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Identification of Low Risk
Patients With Chest Pain in the
Emergency Department: Another
Look at Cardiac Troponins*
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Management of patients with an evolving Q wave myocardial
infarction or high risk unstable angina is now well defined and
mandates rapid institution of therapy proven to reduce mor-
bidity and mortality (1–3). However, optimal treatment of
patients presenting to the emergency room with chest pain and
low clinical risk is less clear and currently entails multiple
approaches (4). These patients represent a continuing chal-
lenge of major magnitude because they comprise a majority of
the 5,000,000 people presenting with chest pain to emergency
departments annually in this country (5). With the develop-
ment of the coronary care unit over three decades ago, it was
advocated that all patients with symptoms suggestive of an
acute myocardial infarction be admitted to these units (6).
Inclusion of patients with compatible symptoms and no objec-
tive evidence of myocardial ischemia resulted in the admission
of a population in which ,30% ultimately had a diagnosis of
myocardial infarction (7). It was also shown (8) that among
such patients, a large group with a ,5% probability of a
cardiac event could be identified by clinical factors, such as
type of chest pain, cardiac history and initial electrocardiogram
(ECG). In a more recent report of .10,000 patients admitted
for acute chest pain, those with a ,1% likelihood of cardiac
complications could be identified by the clinical presentation
(9). The importance of the initial ECG alone as an indicator of
risk is reflected by a complication rate .20-fold higher in
patients presenting with chest pain associated with ECG
abnormalities than in those with normal or near-normal ECGs
(10).
The foregoing findings indicate that among patients pre-
senting with chest pain, a low risk group can be identified in
which intensive coronary care is neither indicated nor benefi-
cial. Recognition of low risk is based on careful patient
assessment and absence of objective evidence of clinical insta-
bility, of which a normal or near-normal ECG is a crucial
element (4,7–10). These concepts have provided the basis for
important alterations in the management of these patients,
aimed at more rational cost-effective care, such as admission to
a step-down unit (11) and observation in a short-stay unit (12).
Other innovations include early triage of low risk patients by
myocardial scintigraphy (13) or echocardiography (14) in the
emergency department and early (15,16) or immediate (17,18)
exercise testing. One of the most promising methods for
identifying risk in patients with acute chest pain is the use of
new serum markers of cardiac injury, of which the troponins
have attracted considerable recent interest.
The cardiac-specific contractile proteins troponin I and T
are highly accurate indicators of myocardial necrosis and are
superior to creatine kinase-MB fraction (19,20). Both tro-
ponins have excellent sensitivity and specificity and can be
measured by a simple, rapid method (21)—essential attributes
of an effective diagnostic marker. The accuracy of troponins I
and T has been confirmed in several large series of high risk
patients with acute coronary syndromes (22–24). These results
were recently extended by Hamm et al. (21) who demonstrated
that negative troponin I or T values were associated with
30-day cardiac event rates of only 0.3% and 1.1% in patients
with chest pain and ECGs without ST segment elevation,
respectively. Hamm et al. concluded that two negative values
of either of the troponins, including one obtained at least 6 h
after the onset of symptoms, permitted safe discharge from the
emergency department. However, their results also indicated
the need for greater caution in patients with ST segment
depression on the initial ECG despite negative values for
troponin I and T, because of short-term event rates that were
not negligible (1.4% and 2.8%, respectively). Prudence is also
dictated by recognition that, of 20 deaths during the 30-day
study period, one (5%) occurred in a patient with negative
troponin I tests, and four (20%) were in patients with normal
troponin T values.
As reported in this issue of the Journal, Polanczyk et al. (25)
investigated the value of troponin further in a representative,
heterogeneous cohort of .1,000 patients presenting to the
emergency department with acute chest pain. They confirmed
the superiority of troponin I to creatine kinase-MB as a marker
for myocardial injury. However, as the authors emphasize,
negative troponin I values obtained during the first 24 h did not
ensure a benign course. Of all patients with negative troponin
I tests, 6% had a major cardiac complication, and in patients
without a myocardial infarction and negative troponin results,
major complications occurred in 5%. In addition, in the 94
patients with cardiac complications, only 47% had abnormal
troponin I values. It was also found that the admission ECG
was the strongest predictor for a major cardiac complication.
Although troponin I was not an independent predictor of
complications, an elevated value raised the risk of an event
more than fourfold in patients with ECG ischemia. The
authors conclude that their findings do not support the routine
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use of cardiac troponin I for emergency department triage of
patients with chest pain.
The studies of Polanczyk et al. (26) and Hamm et al. (21)
demonstrate that the cardiac troponins should be applied
judiciously in patients with chest pain presenting to the emer-
gency department. In each investigation, serial measurements
are fundamental, patient assessment is emphasized, and the
pivotal importance of the initial ECG is confirmed. Both
studies indicate that ECG ischemia increases short-term car-
diac risk appreciably, irrespective of negative troponin values.
It is not surprising that even a method as accurate as the
troponins is imperfect in identifying patients who can be safely
discharged from the emergency department. Limiting factors
include failure to detect minimal myocardial injury, the need
for serial measurements that include a point at least 6 h after
onset of symptoms and inability to predict cardiac complica-
tions unrelated to myocardial ischemia. In this regard, Hamm
et al. (21) restricted end points to myocardial infarction and
death, whereas Polanczyk et al. (25) included events such as
myocardial revascularization, which may be considered a man-
agement decision. Because the latter are not hard end points,
they dilute the sensitivity of the test. At this time, the troponins
may be regarded as an important addition to the history and
ECG in the evaluation of low risk patients presenting to the
emergency department with chest pain, but they should not be
utilized as the sole criterion for this purpose.
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